Join to View Full Profile
201 North Broadway StreetViragh BLDG 5th FLBaltimore, MD 21287
Phone+1 410-955-8964
Fax+1 410-367-2194
Dr. Zaidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2012 - 2015
Icahn School of Medicine at Mount SinaiClass of 2012
Johns Hopkins UniversityFellowship, Medical Oncology
Certifications & Licensure
MD State Medical License 2016 - 2025
LA State Medical License 2020 - 2022
PA State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsDevelopment of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and Challenges.Dan Li, Lalitya Andaloori, Matthew Crowe, Shaoli Lin, Jessica Hong
The American Journal of Pathology. 2025-03-01 - Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.Hassan Sinan, Dea Cunningham, Emy Abou Sleiman, Dana Petry, Thomas McPhaul
JCO Precision Oncology. 2025-02-01 - SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors.Theron Palmer, Michael D Kessler, Xiaoshan M Shao, Archana Balan, Mark Yarchoan
Cancer Research Communications. 2024-12-01
Press Mentions
A Vaccine for Pancreatic Cancer Looks HopefulMay 12th, 2023- Vaccine for ‘Silent Killer’ Pancreatic Cancer Shows Promise: StudyMay 11th, 2023
- Vaccine Slows Return of Pancreatic Cancer in Early TrialMay 11th, 2023
- Join now to see all
Grant Support
- Optimization of an active mutant KRAS peptide vaccine in colorectal cancerJOHNS HOPKINS UNIVERSITY2025–2029
- Mutant KRAS targeted vaccines for the interception of pancreatic cancer developmentJOHNS HOPKINS UNIVERSITY2024–2029
- Mutant KRAS targeted vaccines for the interception of pancreatic cancer developmentJOHNS HOPKINS UNIVERSITY2024–2029
- Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic CancerJOHNS HOPKINS UNIVERSITY2021–2026
- Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic CancerJOHNS HOPKINS UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
